Abstract:Chronic kidney disease (CKD) can be diagnosed by chronic deterioration in kidney function associated with renal parenchymal damage and may progress to end-stage renal disease (ESRD), [ 1 ] which has become a major public health concern. More than 800 million individuals are affected by CKD in 2017, and CKD was predicted to be the fifth leading cause of years of life lost. [ 2 , 3 ] CKD patients had higher mortality rates, [ 4 ] and CKD represents a major public health issue in Taiwan. Wen et al revealed that more than 10% of the Taiwanese population may be affected by CKD. [ 5 ] Comorbidities, such as cardiovascular disease (CVD) and congestive heart failure, not only exacerbate CKD progression but also impact the quality of life and mortality in CKD patients. [ 1 ] Common treatment options for ESRD patients include kidney transplantation and dialysis. [ 6 ] Despite advances in dialysis technology and cardiovascular therapies, cardiovascular-related mortality due to cardiac arrhythmias remains the largest cause of death among patients undergoing general dialysis. In ESRD patients treated with hemodialysis, the incidence of congestive heart failure had increased to 77.3% in 2021. [ 7 ] Given the high morbidity and mortality of these intertwined diseases, the use of hospice palliative care for patients with advanced CKD and CVD is critical to ensure that patients could make informed medical decisions and receive optimal treatment for their needs. Similar to CVD and congestive heart failure, the progression from pre-ESRD to ESRD is highly variable and can follow an unpredictable trajectory. [ 8 , 9 ] Consequently, it is important to understand the progression trajectory to properly initiate and integrate palliative care services, such as the management of patient symptoms and discussion of renal replacement therapy options, including dialysis and non-dialysis management for advanced CKD patients. [ 10 , 11 ] There are already numerous studies on the epidemiology and short-term survival of ESRD patients, [ 12–14 ] but the research on the long-term survival of non-cancer patients with advanced CKD is scarce. Machine learning (ML) has been applied successfully to different chronic diseases, such as chronic liver diseases, CVD, chronic obstructive pulmonary disease, and metabolic syndrome. [ 15–23 ] Furthermore, several studies in the past 2 years have utilized time-series ML techniques to predict the COVID-19 pandemic trend. [ 20 ] Previous studies also used unsupervised learning and network visualization of big data for chronic disease diagnoses. [ 24 ] Machine learning techniques were used in several research about renal problems such as CKD early detection in the EHR database or prediction for acute kidney injury. Several studies have been conducted on the use of artificial intelligence (AI) in ESRD and CKD. [ 20 , 25–29 ] However, these studies mostly focused on CKD prevention or identification. [ 21 , 30–33 ] For mortality prediction in ESRD patients, most studies have focused on populations with only kidney transplant therapy or hemodialysis. [ 34–36 ] Therefore, this study intends to construct a mortality prediction model with AI for pre-ESRD and ESRD patients.

Transformer-based time-to-event prediction for chronic kidney disease deterioration

Prediction of Chronic Kidney Disease Risk Using Multimodal Data

Time-dependent LSTM for Survival Prediction and Patient Subtyping in Kidney Disease Trajectory

Risk prediction for chronic kidney disease progression using heterogeneous electronic health record data and time series analysis

A clinically applicable approach to continuous prediction of future acute kidney injury

Prediction of chronic kidney disease progression using recurrent neural network and electronic health records

TRACE: Early Detection of Chronic Kidney Disease Onset with Transformer-Enhanced Feature Embedding

Computational and Human Intelligence Methods for Constructing Practical Risk Prediction Models: An Application to Cardio-Renal Outcomes in Non-Diabetic CKD Patients

Time-to-event prediction using survival analysis methods for Alzheimer's disease progression

Machine Learning Models for the Prediction of Renal Failure in Chronic Kidney Disease: A Retrospective Cohort Study

Prediction of all-cause mortality for chronic kidney disease patients using four models of machine learning

Predicting chronic kidney disease progression using small pathology datasets and explainable machine learning models

Use of Disease Embedding Technique to Predict the Risk of Progression to End-Stage Renal Disease.

Machine Learning Techniques for Chronic Kidney Disease Risk Prediction

Hi-BEHRT: Hierarchical Transformer-based model for accurate prediction of clinical events using multimodal longitudinal electronic health records

Enhancing End Stage Renal Disease Outcome Prediction: A Multi-Sourced Data-Driven Approach

Specific patterns and potential risk factors to predict 3-year risk of death among non-cancer patients with advanced chronic kidney disease by machine learning

Machine learning for dynamically predicting the onset of renal replacement therapy in chronic kidney disease patients using claims data

Scalable Modeling of Multivariate Longitudinal Data for Prediction of Chronic Kidney Disease Progression

Establishment and Evaluation of Artificial Intelligence-Based Prediction Models for Chronic Kidney Disease under the Background of Big Data

Chronic Kidney Disease Prediction using Machine Learning